The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II...

  • Main
  • 2016 / 6
  • The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II...
Pulmonary Pharmacology & Therapeutics 2016 / 6

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma

Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Pulmonary Pharmacology & Therapeutics
DOI:
10.1016/j.pupt.2016.06.005
Date:
June, 2016
File:
PDF, 992 KB
english, 2016
Conversion to is in progress
Conversion to is failed